Notes:

• Regional and country level aggregate data are generated from regional patient-level databases, using the IeDEA Data Exchange Standard (DES). Data reflects the situation at clinics contributing data to IeDEA, which may not be nationally representative.
• All ART-naïve patients newly enrolling in HIV care from 2010 to present at a site participating in IeDEA were eligible for inclusion if they had at least 15 months between enrollment and database close or transfer to another site of care. The following patients were excluded: patients with incomplete data related to age, sex, and site of enrollment and patients with evidence of ART initiation prior to the date of enrollment.

Definitions:

• Enrollment in HIV care (Newly enrolled): Enrollment in HIV care at a site participating in the IeDEA consortium, based on the date of enrollment recorded in the database.
• Timely ART initiation: Initiation of a combined regimen of antiretroviral therapy (ART) medications within 7 days, 14 days, 30 days, and 12 months after enrollment, or more than 12 months after enrollment.
• Viral load monitoring (VL test recorded): Any record of a viral load test at 6 months (+/- 3 months) and 12 months (+/- 3 months) after enrollment.
• Viral suppression: Viral load <1,000 copies/mL among patients with a recorded viral load test at 6 months (+/- 3 months) and 12 months (+/- 3 months) after the date of enrollment in care at a site participating in IeDEA. Patients with no viral load test result within the ascertainment windows are excluded from viral suppression measures. For patients with >1 viral load test result within the ascertainment window, the lowest recorded viral load measure was used.

Visit the Measures and Methodology page for information about data methods, sources, definitions, and suppression rules.